Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) downgraded to Neutral from Buy at SunTrust following negative CheckMate-026 trial results. The firm also cuts its price target to $68 from $86. 2. FireEye (FEYE) downgraded to Neutral from Overweight at JPMorgan, to Neutral from Buy at Citi, and to Market Perform from Outperform at William Blair. 3. Huntington Ingalls (HII) downgraded to Market Perform from Outperform at Wells Fargo with analyst Sam Pearlstein citing valuation following the company's second quarter results. 4. TripAdvisor (TRIP) downgraded to Hold from Buy at Deutsche Bank with analyst Lloyd Walmsley saying the story is shifting from a "monetization problem to a monetization AND a traffic problem." 5. Apache (APA) downgraded to Equal Weight from Overweight at Barclays with analyst Thomas Driscoll citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
click here.